Accessibility Menu
Tristel Plc logo

Tristel Plc(LSE) TSTL

Market Cap£201.59MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2005)+1,334%
5 Year-29%
1 Year+13%
1 Month+8%
£4.30
+2.38%
+0.10Today
Tristel Plc last closing stock price
MetricPriceDate
Last closeGBX 430.002026-07-30
Tristel Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+9.55%GBX 392.502026-07-23
1 month+7.5%GBX 400.002026-06-30
3 month+6.17%GBX 405.002026-05-01
Year to date+2.99%GBX 417.502025-12-31
1 year+12.71%GBX 381.502025-07-30
3 year+21.13%GBX 355.002023-07-31
5 year-28.69%GBX 603.002021-07-30
Since inception+1,333.65%GBX 0.292005-06-01

Tristel Plc Financials at a Glance

Market Cap

£201.59MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

£93.10M

Net Income (TTM)

£14.00M

EPS (TTM)

£0.16

P/E Ratio

25.49

Dividend

£0.14

Beta (Volatility)

-0.05 (Low)

Price

£4.30

Volume

186,787

Open

£4.15

Previous Close

£4.30

Daily Range

£4.15 - £4.30

52-Week Range

£3.50 - £4.50

Estimated Earnings Date

Oct 19, 2026

TSTL News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Tristel Plc

Tristel PLC is a UK-based company specializing in the development and distribution of infection prevention products. The firm operates in the healthcare sector, focusing on decontamination solutions for medical devices and environmental surfaces.

Products and Services
  • Disinfection solutions for medical instruments under the Tristel brand
  • Decontamination products for hospital environments
  • Specialized products for various clinical areas, including ENT and urology
Growth Outlook
  • Revenue increased to £25.6 million in the latest quarter
  • Net income rose to £3.95 million, reflecting strong operational efficiency
  • Consistent demand for infection control products supports future growth
Financial Highlights
  • Trailing twelve-month revenue of £94.5 million, showcasing robust performance
  • Net profit margin of 15.9%, indicating effective cost management
  • Dividend yield of 3.55%, appealing for income-focused investors
Tristel PLC has established itself as a key player in the infection prevention market, with a diverse range of products catering to various medical fields. The company's recent financial performance demonstrates a solid upward trajectory, with significant revenue growth and profitability. The strong demand for its disinfection solutions positions Tristel favorably for continued expansion in both domestic and international markets. The company's commitment to innovation and quality further enhances its competitive edge, making it an attractive option for potential investors interested in the healthcare sector.
AI Generated • Jul 2, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

267

CEO

Matthew Giovanni Sassone

Website

www.tristel.com

Headquarters

Newmarket, EA CB8 7NY, GB

TSTL Financials

Key Financial Metrics (TTM)

Gross Margin

78.65%

Operating Margin

19.72%

Net Income Margin

15.88%

Return on Equity

23.64%

Return on Capital

21.60%

Return on Assets

17.31%

Earnings Yield

3.92%

Dividend Yield

3.38%

Payout Ratio

86.18%

Stock Overview

Market Cap

£201.59MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

48.00M

Volume

186.79K

Avg. Volume

148.87K

Financials (TTM)

Gross Profit

£72.22M

Operating Income

£17.02M

EBITDA

£23.12M

Operating Cash Flow

£21.52M

Capital Expenditure

-£2.08M

Free Cash Flow

£19.44M

Cash & ST Invst.

£13.29M

Total Debt

£5.82M

Tristel Plc Performance Analysis

Tristel Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30GBP 31,123,000N/A
20232023-06-30GBP 36,009,00015.7%
20242024-06-30GBP 41,933,00016.5%
20252025-06-30GBP 46,462,00010.8%
Tristel Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-30N/A
Q22024-12-31N/A
Q42025-06-30N/A
Q22025-12-31N/A
Tristel Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30GBP 0.02N/A
20232023-06-30GBP 0.09355.1%
20242024-06-30GBP 0.1443.9%
20252025-06-30GBP 0.142.0%
Tristel Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-30N/A
Q22024-12-31N/A
Q42025-06-30N/A
Q22025-12-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

£25.65M

+22.5%

Gross Profit

£19.59M

+11.7%

Gross Margin

76.38%

N/A

Market Cap

£201.59MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

£746.62K

N/A

Employees

270

N/A

Net Income

£3.95M

+28.3%

EBITDA

£6.51M

+50.3%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

£13.29M

+23.4%

Total Debt

£5.82M

-2.2%

Accounts Receivable

£8.79M

+28.3%

Inventory

£4.32M

-2.9%

Long Term Debt

£4.71M

-8.3%

Short Term Debt

£1.11M

+36.4%

Return on Assets

17.31%

N/A

Return on Invested Capital

25.03%

N/A

Free Cash Flow

£5.10M

-1.4%

Operating Cash Flow

£5.41M

+0.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
OPT.LOptima Health plc
£2.37+0.00%
BXP.LBeximco Pharmaceuticals Limited
£0.52+0.00%
ANCR.LAnimalcare Group plc
£3.35+0.45%
DXRX.LDiaceutics PLC
£1.37+3.41%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$91.13+0.11%
NVDANvidia
$195.04+0.03%
MSFTMicrosoft
$451.10+0.16%
NOKNokia
$9.09+0.08%

Questions About TSTL

What is the current price of Tristel Plc?

Tristel Plc is trading at £4.30 per share.

What is the 52-week range for Tristel Plc?

Over the past 52 weeks, Tristel Plc has traded between £3.50 and £4.50.

How much debt does Tristel Plc have?

As of the most recent reporting period, Tristel Plc reported total debt of £5.88M.

How much cash does Tristel Plc have on hand?

Tristel Plc reported £12.84M in cash and cash equivalents in its most recent financial results.

What is Tristel Plc’s dividend yield?

Tristel Plc currently has a dividend yield of 3.38%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services